Opus Genetics (IRD) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.26% |
| Dec 31, 2025 | 70.04% |
| Sep 30, 2025 | 34.17% |
| Jun 30, 2025 | 31.57% |
| Mar 31, 2025 | 29.15% |
| Dec 31, 2024 | 62.85% |
| Sep 30, 2023 | -52.45% |
| Jun 30, 2023 | -47.23% |
| Mar 31, 2023 | -46.05% |
| Dec 31, 2022 | -45.20% |
| Sep 30, 2022 | -38.42% |
| Jun 30, 2022 | -37.90% |
| Mar 31, 2022 | -35.98% |
| Dec 31, 2021 | -35.37% |
| Sep 30, 2021 | -35.30% |
| Jun 30, 2021 | -35.24% |
| Mar 31, 2021 | -34.92% |
| Dec 31, 2020 | -34.13% |
| Sep 30, 2020 | -15.12% |
| Jun 30, 2020 | -5.94% |
| Mar 31, 2020 | -3.59% |
| Dec 31, 2019 | -22.38% |
| Sep 30, 2019 | 3.19% |
| Jun 30, 2019 | 9.30% |
| Mar 31, 2019 | 10.58% |
| Dec 31, 2018 | 11.53% |
| Sep 30, 2018 | 11.89% |
| Jun 30, 2018 | 22.66% |
| Mar 31, 2018 | 20.28% |
| Dec 31, 2017 | 18.42% |
| Sep 30, 2017 | 4.85% |
| Jun 30, 2017 | 3.45% |
| Mar 31, 2017 | -0.03% |
| Dec 31, 2016 | -1.28% |
| Sep 30, 2016 | 0.84% |
| Jun 30, 2016 | 0.86% |
| Dec 31, 2015 | -1.79% |